Overhauling oversight--European drug legislation.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16151389.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
At the end of next month, the European Medicines Agency (EMEA) will implement a new legislative framework and several provisions that seek to provide incentives and streamline regulatory oversight of certain monoclonal antibodies and other biologic products.
Medical subject headings
- Drug Approval
- Drug Industry
- Legislation, Drug